Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Enrolling by invitation · Phase 2
Conditions studied: Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
In brief
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)
Key facts
- Study ID
- NCT07734415
- Run by
- Inmagene LLC
- People needed
- 400
- Starts
- 2026-06-05
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Inmagene Site 1 — Lancaster, California, United States
- Inmagene Site 23 — Los Angeles, California, United States
- Inmagene Site 19 — Ocala, Florida, United States
- Inmagene Site 4 — Tampa, Florida, United States
- Inmagene Site 2 — Rolling Meadows, Illinois, United States
- Inmagene Site 6 — Kew Gardens, New York, United States
- Inmagene Site 21 — New York, New York, United States
- Inmagene Site 11 — Woodbury, New York, United States
- Inmagene Site 20 — Charlotte, North Carolina, United States
- Inmagene Site 10 — Fargo, North Dakota, United States
- Inmagene Site 9 — Columbus, Ohio, United States
- Inmagene Site 5 — Mayfield Heights, Ohio, United States
- Inmagene Site 3 — Portland, Oregon, United States
- Inmagene Site 12 — Anderson, South Carolina, United States
- Inmagene Site 8 — Southlake, Texas, United States
- Inmagene Site 7 — Burien, Washington, United States
- Inmagene Site 15 — Surrey, British Columbia, Canada
- Inmagene Site 22 — Vancouver, British Columbia, Canada
- Inmagene Site 17 — Greater Sudbury, Ontario, Canada
- Inmagene Site 13 — Mississauga, Ontario, Canada
- Inmagene Site 18 — North Bay, Ontario, Canada
- Inmagene Site 14 — Montreal, Quebec, Canada
- Inmagene Site 16 — Saskatoon, Saskatchewan, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.